Genprex Inc. (GNPX)

Genprex stock forecast: buy or sell

Genprex stock outlook

  • Genprex closed today at $2.96 after climbing a 2.07% and broke a streak of 3 sessions in positive.
  • The stock is configuring an uptrend pattern since December 2019, when it bottomed at $0.23. This uptrend marked a 1186.96% gain
  • Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform.
No ad for you

Important note:
The viewpoints contained in this article are personal and not recommendations for you to buy or sell stocks. The author of this text does not have an understanding of the particular positions of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are published for educative purposes only

Genprex stock chart overview

Should I buy Genprex stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is GNPX stock a buy?

Currently, Genprex stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for GNPX in coming sessions, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

No ad for you

Should I sell Genprex stock?

Do you know when is it time to sell Genprex stock?. As when we have to buy shares, determining when is appropiate time to sell is not a fickle decision, and we must use our own trading style. We like very simple setups to guide us on when is a good time to sell a stock. Be aware that these setups are not intended for selling short Genprex stock

As a rule of thumb, you should not keep a trading operation that leads to losses greater than those expected upon the buy. The moment to sell your stock always has to be dictated by the stop-loss (automatic or manual)

Is it time to sell Genprex stock?

Currently, Genprex stock doesn't match any of our preferred sell setups, so if you own Genprex stock and your operation is in profit probably is not time to sell now

Price lost SMA50 level

Since Genprex moved up above the 50-day MA in early May price gained a 11.23%. However, that positive trend may have ended, or be showing signs of exhaustion, by now that the price fell below that moving-average level yesterday. For mid-term investors who have benefited from the stock during the time the price was over the average, this signal should be a wake-up call and a trigger to sell the shares and cash in on their returns

No ad for you

Analysts' recommendations to buy or sell Genprex stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

We don't have any rating posted in the previous month for Genprex

No ad for you

Technical analysis

Genprex stock started an uptrend on December 2019, and gained an amazing 1186.96%. During this uptrend, the price offered some entry points on the breakouts. Latest pullback was in mid-June, when price bounced at $2.76. Now, it trades in a consolidation between its last top ($3.80) and its last bottom ($2.76)

SMAs overview

A favorite tool of many technical analysts are the moving averages, that easily show market direction. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages. Further about Moving Averages from sources like Wikipedia and Investopedia

Supports and resistances

Traders use support and resistance levels to identify price points in the stock price action that tend to behave as barriers, preventing the price of shares to move up or down. Supports are levels where the price may find support as it falls. This means that the price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down this level, it will probably continue falling until approaching another support level. On the other side, resistance levels are where the price may find opposition as it moves up. In the same manner, the price is more likely to "bounce off" at this level, and if it finally breaches this level, it will rally more easily until it hits the next resistance

The current resistance levels are:

  • R1: $3.46 (16.89% above)
  • R2: $3.80 (28.38% above)
  • R3: $4.55 (53.72% above)
  • The current support levels are:

  • S1: $2.76 (-6.76% below)
  • S2: $2.56 (-13.51% below)
  • S3: $2.00 (-32.43% below)
  • Bollinger bands

    This is an indicator that was designed in the 1980s by John Bollinger. It consists of three bands that are plotted superimposed on the price evolution chart:

    • The central band is a moving average, usually a simple moving average calculated with 20 periods
    • The upper band is calculated by adding to the value of the simple moving average 2 times the standard deviation of the moving average
    • The lower band is calculated by subtracting from the simple moving average 2 times the standard deviation of the moving average

    Relative strength index

    The Relative Strength Index is an oscillator-type indicator that gauges price action to reveal when the price of a share or financial asset is oversold or overbought. Oscillator indicators, such as relative strength, are intended to indicate values in the range of 0-100. J. Welles Wilder introduced the relative strength indicator in 1978 and since then it has been widely used by traders

    When the relative strength (RSI) moves for so long below 70 and above 30, without indicating moments of overbought and oversold, the indicator turns out to be of little use, and we find ourselves in one of these situations.

    No ad for you

    Earnings and financials

    Genprex Inc. (GNPX) published Q1 earnings of $-0.08 per share, matching the Market consensus estimate of $-0.08 per share. Reported sales were $0.00, consistent with analysts' estimates as well.

    Same quarter one year ago, reported EPS was $-0.23, so recently posted EPS means a gain of 65.22%. Looking at revenue, figures scarcely changed compared to $0.00 same quarter last year.

    Genprex will host the quarterly earnings call on mid next August. Market estimates earnings of %s a share of $-0.07, compared to previous quarter that made $-0.08. Earnings reporting day has a more than usual risk for investors as the data disclosed can soar and sink the stock price with very low liquidity and not honouring your buy/stop-loss orders. Check company's website to confirm time and details on the earnings call and the earnings report.

    No ad for you